Sectors
AURA
Aura Biosciences, Inc.
7.99
1 x 7.97
1 x 9.11
bid
ask
+
0.27
3.50%
1 @ 04:00 PM
8.04 +0.05 (0.63%)
| Ytd | 46.61% | |
| 1y | 21.98% |
7.72
day range
8.00
4.73
52 week range
9.54
| Open | 7.81 | Prev Close | 7.72 | Low | 7.72 | High | 8.00 | Mkt Cap | 826.46M |
| Vol | 526.75K | Avg Vol | 556.79K | EPS | -1.74 | P/E | -4.59 | Forward P/E | -4.05 |
| Beta | 0.33 | Short Ratio | 4.79 | Inst. Own | 77.55% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-11 | 50-d Avg | 6.96 | 200-d Avg | 6.38 | 1yr Est | 21.83 |
| Income Statement | |||
| Operating Expenses | 34.87M | ||
| Research and Development Expense | 27.96M | ||
| Selling, General and Administrative Expense | 6.91M | ||
| Operating Income | -34.87M | ||
| Income Tax Expense | 11.00K | ||
| Net Income | -33.68M | ||
| Net Income Common Stock | -33.68M | ||
| Net Income Common Stock (USD) | -33.68M | ||
| Consolidated Income | -33.68M | ||
| Earnings per Basic Share | -0.50 | ||
| Earnings per Basic Share (USD) | -0.50 | ||
| Earnings per Diluted Share | -0.50 | ||
| Earning Before Interest & Taxes (EBIT) | -33.67M | ||
| Earning Before Interest & Taxes (USD) | -33.67M | ||
| Weighted Average Shares | 67.45M | ||
| Weighted Average Shares Diluted | 67.45M | ||
| Balance Sheet | |||
| Cash and Equivalents | 85.56M | ||
| Cash and Equivalents (USD) | 85.56M | ||
| Investments | 29.94M | ||
| Investments Current | 29.94M | ||
| Current Assets | 118.50M | ||
| Property, Plant & Equipment Net | 17.89M | ||
| Total Assets | 137.68M | ||
| Debt Current | 3.27M | ||
| Total Debt | 16.99M | ||
| Current Liabilities | 16.71M | ||
| Debt Non-Current | 13.72M | ||
| Total Liabilities | 30.43M | ||
| Accumulated Retained Earnings (Deficit) | -514.10M | ||
| Accumulated Other Comprehensive Income | -207.00K | ||
| Shareholders Equity | 107.25M | ||
| Shareholders Equity (USD) | 107.25M | ||
| Assets Non-Current | 19.17M | ||
| Total Debt (USD) | 16.99M | ||
| Liabilities Non-Current | 13.72M | ||
| Trade and Non-Trade Payables | 2.57M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 686.00K | ||
| Net Cash Flow from Financing | 300.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 25.31M | ||
| Capital Expenditure | -102.00K | ||
| Issuance (Purchase) of Equity Shares | 300.00K | ||
| Net Cash Flow from Investing | 54.90M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 55.00M | ||
| Net Cash Flow from Operations | -29.89M | ||
| Effect of Exchange Rate Changes on Cash | -27.00K | ||
| Share Based Compensation | 3.82M | ||